Web3 AI Platform Neuramint Completes $5M Seed Round

iconKuCoinFlash
Share
Share IconShare IconShare IconShare IconShare IconShare IconCopy
AI summary iconSummary

expand icon
Web3 adoption continues as Neuramint, a Web3 AI agent platform, announced a $5 million seed round on January 12, 2026. Maelstrom, Borderless Capital, Selini Capital, Symbolic Capital, Lattice Fund, and Node Capital led the funding. The capital will accelerate platform development, expand integration of Web3-native SDKs, and support the public testing of the Neuramint Beta. Additional funds will also enhance DeFi automation, NFT operations, cross-chain bridging, and DAO governance. This Web3 news marks a significant milestone in the platform's growth.

BlockBeats news: On January 12, according to an official announcement, Web3 AI agent platform Neuramint revealed it has successfully closed a $5 million seed funding round. Investors in this round include Maelstrom, Borderless Capital, Selini Capital, Symbolic Capital, Lattice Fund, and Node Capital.


It is understood that this funding will accelerate platform development, expand the integration of Web3-native SDKs, and support the upcoming public beta test of Neuramint. The new capital will also drive further integration with major DeFi protocols and blockchain networks, supporting DeFi automation, NFT operations, cross-chain bridging, and large-scale DAO governance.

Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information. Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.